Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-21 @ 9:59 PM
Study NCT ID:
NCT03137160
Status:
COMPLETED
Last Update Posted:
2024-02-23
First Post:
2017-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
Sponsor:
Ohio State University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pyoderma Gangrenosum | View |
Keywords: